Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479817
Status:
COMPLETED
Last Update Posted:
2019-12-18
First Post:
2007-05-24
Brief Title:
Phase 2 AMG 386 in Comb Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2009-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-24
First Submit QC Date:
May 24 2007
Study First Post Date:
2007-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2015-10-29
Disp First Submit QC Date:
October 29 2015
Disp First Post Date:
2015-11-25
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-12-16
Last Update Post Date:
2019-12-18
Last Update Post Date Type:
ACTUAL